Robert J. Schroth

Aug 20, 2024 | medrxiv.org | Anil Menon |Olubukola Olamide Olatosi |Robert J. Schroth |Saif Goubran

AbstractIntroduction: In 2022, the Government of Canada introduced the Interim Canada Dental Benefit (CDB) to support Canadian families with children < 12 years of age. This program operated from October 1, 2022, to June 30, 2024, with two application periods. The purpose of this study was to analyze data on applications accepted by the Canada Revenue Agency (CRA) during the first 18 months of the program.

May 10, 2024 | medrxiv.org | Anil Menon |Jorma I Virtanen |Robert J. Schroth

The authors have declared no competing interest. Funding for this research was made possible from a Canadian Institutes of Health Research Applied Public Health Chair in Public Health Approaches to Improve Access to Oral Health Care and Oral Health Status for Young Children in Canada. I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Mar 4, 2024 | kelowna.ca | Robert J. Schroth

From public notices to Council agendas, career posting to bidding opportunities, we offer quick and timely email updates on a number of topics.

Jan 20, 2024 | biorxiv.org | Nisha Singh |Robert J. Schroth |Ben Ulmer |Manoj Medapati

AbstractMacroautophagy (hereafter autophagy) is a lysosomal degradation pathway that functions in nutrient recycling and as a mechanism of innate immunity. Previously we reported, a novel host-bacteria interaction between cariogenic S. mutans and bitter taste receptor (T2R14) in gingival epithelial cells (GEC) leading to an innate immune response. Further, S. mutans might be using the host immune system to inhibit other Gram-positive bacteria, such as S. aureus.